
Other pipeline developments include an agent to control pain in IC/BPS patients, an antibody to treat prostate and bladder cancer, an injectable OAB treatment, and more.
Ben Schwartz is Associate Editor, Contemporary OB/GYN.

Other pipeline developments include an agent to control pain in IC/BPS patients, an antibody to treat prostate and bladder cancer, an injectable OAB treatment, and more.

Other products discussed include cancer tests, an app to connect patients with specialists, a revenue management system, and more

Other pipeline developments include a new company formed to develop OAB treatments, a phase III urothelial cancer study meeting its primary endpoint, the formation of a partnership to study RCC treatment, and more.

Other pipeline developments include efficacy results for a bladder and prostate cancer drug, an infertility tool to predict sperm quality, the initiation of an immunotherapy combination for mUC, and more.

Other products discussed include an updated prostate tissue ablation device, a contrast agent for voiding ultrasonography, a bladder cancer test and more.

Other pipeline developments discussed include an implantable device for OAB treatment, a subcutaneous hypogonadism treatment, efficacy results for an HPV drug, and the status of a device-based BPH treatment.

Other products discussed include a stent system for treating ureteral obstructions, a male infertility test, and more.

Other pipeline developments discussed include a bladder cancer test, a male infertility assay, and the first oral dosage treatment for hypogonadism.

Other new products discussed in this article include a surgical training model, devices designed to improve prostate biopsy accuracy, an updated label and more.

Other pipeline developments discussed in this article include the initiation of an intravesical bladder cancer study, a gel treatment for ED that has met its primary endpoint, a patent awarded for the first rechargeable implantable SNM along with some other advancements.

A bladder cancer drug-device combination, a localized prostate cancer agent, and a new surgical robot are among other treatments in the pipeline discussed in this round-up.

Other products discussed in this roundup include a smart-mobile connected ultrasound device, treatments for RCC, and more.

Other products discussed in this roundup include a plasma vaporization device, a laser fiber safety device, and more.

Published: January 13th 2017 | Updated:

Published: August 30th 2016 | Updated:

Published: July 15th 2016 | Updated:

Published: July 20th 2016 | Updated:

Published: February 10th 2017 | Updated:

Published: April 6th 2017 | Updated: